Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
The Top Weight Loss.com
Guides7 min read

GLP-1 Side Effects: What to Expect in Your First 12 Weeks

Most GLP-1 side effects are digestive and peak right after dose increases. Here's a week-by-week guide to the first three months, practical ways to manage them, and the warning signs that need urgent care.

Key takeaways

  • Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, reduced appetite, reflux and fatigue - usually worst during dose escalation.
  • Serious side effects are rare but include pancreatitis, gallbladder disease, kidney injury from dehydration, and low blood sugar when combined with some diabetes medications.
  • GLP-1s carry a boxed warning about thyroid C-cell tumors in rodents and are not used with a personal or family history of medullary thyroid carcinoma or MEN2, or in pregnancy.

Why side effects follow the dose schedule

Semaglutide and tirzepatide slow how quickly your stomach empties and turn down appetite signals. That is how they work - and it is also why most side effects are digestive. Treatment starts at a low dose and is stepped up gradually, typically about every four weeks, so your body can adjust. The pattern most people notice: side effects flare for a few days after each increase, then settle.

Over 12 weeks you will usually move through your starting dose and one or two increases, as your clinician decides. Not everyone gets side effects, and severity varies a lot from person to person.

Week-by-week: what to expect

  • Weeks 1-2 (starting dose): Appetite often drops within days. Mild nausea, feeling full quickly, burping or reflux are common, especially 1-3 days after the injection. Some people feel tired. Weight changes early are often partly water.
  • Weeks 3-4: Many people settle into a rhythm. Constipation can show up as you eat less. This is a good time to lock in hydration, fiber and protein habits.
  • Weeks 5-8 (first increase): Expect a short flare of nausea or bowel changes after stepping up. If it is manageable, it usually eases within days. If you are struggling to eat or drink, tell your clinician before your next increase.
  • Weeks 9-12 (next increase, if prescribed): Appetite suppression is typically stronger. The risk now is under-eating - skipping meals, too little protein and too little fluid - which can worsen fatigue, dizziness and constipation.

Your clinician can slow the titration or keep you at a dose longer. Moving up is not a race - staying at a tolerable dose is a normal decision.

Top-Rated Providers

1
Our Top Pick
embody logo
9.8
Exceptional

Compounded semaglutide and tirzepatide at a flat monthly price - no commitment, shipped in 1-2 days

  • Semaglutide $69/mo, tirzepatide $119/mo
  • Month-to-month - cancel anytime
  • Ships in 1-2 days, cold-chain packed
  • LegitScript-certified clinicians

Free & Discreet Shipping

Visit Site
2
ro logo
9.6
Excellent

Brand-name, FDA-approved GLP-1s only - Wegovy, Zepbound, Ozempic and Foundaya - with an insurance concierge

  • FDA-approved brand-name medication only
  • Insurance checks & prior authorizations handled
  • Membership $39 first month
  • Unlimited provider messaging
Visit Site
3
altRx logo
9.3
Excellent

One flat price at every dose for compounded GLP-1s, plus a brand-name shelf in the same account

  • Semaglutide $89/mo, tirzepatide $149/mo (promo)
  • Same price at every dose
  • Brand-name Wegovy, Zepbound & Ozempic available
  • Buy Now, Pay Later available
Visit Site

Practical ways to manage common side effects

  • Nausea: eat smaller meals, stop at the first sign of fullness, and go easy on greasy, fried or very sweet foods. Bland foods help on injection days.
  • Reflux: avoid lying down for a few hours after eating and skip large late-night meals.
  • Constipation: drink plenty of water, add fiber gradually, and stay active. Ask your clinician before using laxatives regularly.
  • Diarrhea or vomiting: prioritize fluids and electrolytes - dehydration is how minor side effects become serious ones.
  • Fatigue: often a sign of eating too little. Aim for protein at every meal.

Use your provider's messaging: services like trimrx (unlimited check-ins), ro (unlimited messaging) and embody (care-team messaging) let you ask about side effects between visits, and MEDVi includes dietitian access for help eating well on a smaller appetite.

When should you get urgent care?

Seek prompt medical attention - and stop taking the medication until a clinician advises you - if you have:

  • Severe, persistent abdominal pain, especially if it spreads to your back, with or without vomiting (possible pancreatitis).
  • Pain in the upper right abdomen, fever, yellowing skin or eyes, or clay-colored stools (possible gallbladder problem).
  • Being unable to keep fluids down, very little or dark urine, or dizziness when standing (dehydration, which can injure the kidneys).
  • Shakiness, sweating, confusion or a racing heart if you also take insulin or a sulfonylurea (possible low blood sugar).
  • A lump or swelling in the neck, trouble swallowing or persistent hoarseness.
  • Signs of a serious allergic reaction - swelling of the face, lips or throat, or trouble breathing. Call emergency services.

If you become pregnant or plan to, tell your clinician right away - GLP-1s are not for use in pregnancy.

Make the next 12 weeks easier

  • If side effects are mild, stick with the plan and use the tips above - they usually fade.
  • If they flare after every increase, ask about a slower titration or custom dosing.
  • If one drug stays hard to tolerate, ask whether switching is appropriate - see semaglutide vs tirzepatide.

Thinking long term? Read what happens when you stop a GLP-1, or compare providers on support and price in our GLP-1 provider rankings.

This article is general information, not medical advice. A licensed clinician should decide what treatment, if any, is right for you. Results vary.

Ready to compare GLP-1 providers?

See how top providers stack up on pricing, medical support, and treatment options.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  2. 2.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize - U.S. Food & Drug Administration
  3. 3.Wegovy (semaglutide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
  4. 4.Zepbound (tirzepatide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
  5. 5.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) - Wilding et al. - New England Journal of Medicine, 2021;384:989-1002
  6. 6.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) - Jastreboff et al. - New England Journal of Medicine, 2022;387:205-216
  7. 7.Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) - Aronne et al. - New England Journal of Medicine, 2025
  8. 8.Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension - Wilding et al. - Diabetes, Obesity and Metabolism, 2022
  9. 9.Prescription Medications to Treat Overweight & Obesity - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH